Effects of L-DOPA treatment on indole metabolism in Parkinson's disease.
D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine*; D007210:Indoleacetic Acids / Q000652:urine*; D007211:Indoles / Q000378:metabolism*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism; D013237:Stereoisomerism; D014363:Tryptamines / Q000652:urine*
D007210:Indoleacetic Acids; D007211:Indoles; D014363:Tryptamines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine